Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-01-25

FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)

View source ↗

Summary

FDA approves a supplemental application for ARISTADA (aripiprazole lauroxil) submitted by Alkermes, Inc. The approval updates the drug's labeling and/or indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARISTADA (ARIPIPRAZOLE LAUROXIL)

Snippet

SUPPL AP for ARISTADA (ARIPIPRAZOLE LAUROXIL)